OSW-1 inhibits tumor growth and metastasis by NFATc2 on triple-negative breast cancer.

Cancer Medicine
Xiaorong DingYongmei Yin

Abstract

OSW-1 is a natural compound extracted from the bulbs of Ornithogalum saundersiae in 1992. It has been shown strong antitumor activities in various cancer cells. However, the effects of OSW-1 on tumor growth and metastasis in breast cancer are still poorly understood. In our research, we showed that OSW-1 had a strong anticancer effect on breast cancer cells, but lower toxicity to normal cells. Accordingly, it also revealed significant inhibition of tumor growth by OSW-1 in xenograft model. In addition, we performed Annexin V/PI-labeled flow cytometric assay and TUNEL assay and showed that OSW-1 inhibited tumor growth by inducing apoptosis. Furthermore, we carried out transwell assays and found that OSW-1 significantly repressed the migratory and invasive capabilities of triple-negative breast cancer (TNBC) cells via mediating epithelial-mesenchymal transition. Besides, OSW-1 also could inhibit metastasis in an orthotopic model and resulted in a longer survival compared with control group. Finally, we performed RNA-sequencing and cellular functions to investigate the molecular mechanism of how OSW-1 inhibits TNBC, and identified NFATc2 may as a pivotal factor for OSW-1-mediated effects on cell death, tumor growth, invasion, and ...Continue Reading

References

Feb 15, 2001·Journal of Natural Products·M KurodaJ A Beutler
Oct 25, 2001·The Journal of Organic Chemistry·Shaojiang DengYongzheng Hui
Dec 8, 2005·Journal of the National Cancer Institute·Yan ZhouPeng Huang
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eva S ThomasHenri H Roché
Feb 19, 2010·The Cancer Journal·Sally Greenberg, Hope S Rugo
Oct 1, 2010·Annals of Surgical Oncology·Julie A Y BillarBarbara A Pockaj
Nov 12, 2010·The New England Journal of Medicine·William D FoulkesJorge S Reis-Filho
Jan 13, 2011·Cancer Immunology, Immunotherapy : CII·Miriam B F WerneckJoão P B Viola
Dec 20, 2012·The Journal of Biological Chemistry·Celia Garcia-PrietoPeng Huang
Jan 25, 2013·Nature Reviews. Cancer·Bram De Craene, Geert Berx
Jul 12, 2013·Drugs·Valentina GuarneriPierfranco Conte
Oct 22, 2013·Genes & Development·Jeff H Tsai, Jing Yang
Feb 22, 2014·Nature Reviews. Molecular Cell Biology·Samy LamouilleRik Derynck
Mar 13, 2014·American Journal of Clinical Pathology·Robert SchmadekaMeenakshi Singh
Jul 30, 2014·Biochimica Et Biophysica Acta·Jiang-Jiang QinRuiwen Zhang
Jan 30, 2015·Clinical & Experimental Metastasis·L GerratanaF Puglisi
Mar 10, 2015·Journal of Clinical Pathology·Hirofumi MatsumotoJabed Iqbal
Mar 19, 2015·Breast Cancer Research and Treatment·Karin KastPauline Wimberger
Oct 19, 2016·Nature Reviews. Clinical Oncology·Giampaolo BianchiniLuca Gianni
Aug 30, 2016·World Journal of Gastroenterology : WJG·Simona GurzuIoan Jung
Nov 1, 2017·World Journal of Gastroenterology : WJG·Yirui GuiSubburaj Ilangumaran

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
xenograft
flow cytometry
xenografts

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.